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Purpose: The intracellular signalling mechanisms that modulate the sustained vascular 
smooth muscle contractions that occur with vasospasm are not well tmderstood. The 
purpose of this investigation was to examine cell signalling mechanisms that account for 
sustained vascular smooth muscle contraction, independent of increases in intracellular 
Ca e+ concentrations ([Ca2+]i). 
Methods: Fresh bovine carotid artery smooth muscles contractile responses were examined 
in a muscle bath. [Ca2+]i was depleted by use of the extracellular Ca 2+ chelator, ethylene 
glycol-bis(6-aminoethylether) N, N, N', N'-tetraacetic a id and the intracellular chelator, 
1,2-bis(2-aminophenoxy)ethane-N,N,N',N',-tetraacetic acid. 
Results: In Ca2+-free conditions, depolarizing the membrane with high extracellular KCI 
failed to elicit a contraction. In addition, in Ca e + -free conditions the ([Ca e+ ]i) was less than 
10 nmol/L as determined with the Cae+-indicator, Fura 2. The protein kinase C (PKC) 
activator, phorbol 12, 13-dibutyrate (PDBu), induced slowly developing sustained 
contractions in bovine carotid artery smooth muscle, and the magnitude of the contractile 
response to PDBu (10 nmol/L to 10 ismol/L) was the same in the presence and absence 
of Ca 2+. PDBu induced contractions in Ca2+-free conditions were not inhibited by the 
myosin light chain kinase inhibitor, ML-9 (50 ~mol/L), but were inhibited by the PKC 
inhibitor, staurosporine (50 nmol/L). 
Conclusions: These data suggest that vascular smooth muscle contractions can occur under 
conditions where the [Ca2+]i is low and fixed and that these contractions may be mediated 
by PKC. (J VAsc SURG 1995;22:37-44.) 
Vascular smooth muscle is unique in that sus- 
tained contractions can be maintained with minimal 
energy expenditure. Sustained vascular smooth 
muscle contraction is important for maintaining 
vasomotor tone. However, sustained vascular 
smooth muscle contraction may be deleterious in 
pathologic vasospasm. Vasospasm contributes to 
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mesenteric ischemia, myocardial infarction, and 
stroke associated with subarachnoid hemorrhage 
and often complicates peripheral arterial reconstruc- 
tions. 
The initiation of contraction in vascular smooth 
muscle is believed to arise from an increase in 
intracellular Ca 2+ with activation of  the Ca 2+- 
calmodulin-dependent zyme, myosin light chain 
kinase (MLCK) that in turn phosphorylates 20 kd 
myosin light chains.1 However, considerable contro- 
versy exists regarding the mechanisms involved in the 
maintenance of vascular smooth muscle contraction. 
This controversy centers on data that show that 
sustained vascular smooth muscle contractions can be 
maintained independent of  changes in intracellular 
calcium concentration ([CaZ+]i) and the extent of 
myosin light chain phosphorylation, z-4 To account 
for these data, the "latch bridge hypothesis" has been 
proposed that suggests that dephosphorylation f  
myosin generates a slowly cycling cross-bridge, the 
latch bridge, which is responsible for force mainte- 
nance, s Alternatively, a number of  investigators have 
37 
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Fig. 1. Contractile response to repeated additions of serotonin in Ca2+-free conditions. This 
is representative tracing of response of BCASM strips to repeated additions of serotonin (5-HT, 
2+ 10 ~mol/L, at 30 minute intervals) after equilibration i  Ca -free (+ 4 mmol/L EGTA and 0.1 
mmol/L BAPTA) buffer. Contractile response progressively diminished, suggesting that 
intracellular Ca 2+ stores were eventually depleted. After 3 to 5 additions of 5-HT contractile 
response was less than 5% of response in presence of Ca 2÷. 
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Fig. 2. Contractile responses of BCASM induced by PDBu in presence and absence of Ca 2+. 
BCASM strips were equilibrated in normal bicarbonate buffer for 60 minutes. Baseline 
contractile responses to 110 mmol/L KCL and serotonin (5HT, 10 ~mol/L) were determined 
in Ca 2+ containing buffer. Some muscle strips were then incubated in Caa+-free (+4 mmol/L 
EGTA and 0.1 mmol/L BAPTA) buffer for 60 minutes and then treated with PDBu (300 
nmol/L) until contraction reached plateau. PDBu elicited slowly developing, sustained 
contractions of similar magnitude in presence (A) and absence (B) of Ca 2+. These are actual 
tracings that are representative of at least 8 separate xperiments. 
proposed that activation of other kinase cascades may 
be important for the sustained phase of vascular 
smooth muscle contraction. 68
A significant body of data supports a role for 
protein kinase C (PKC) in sustained vascular smooth 
muscle contraction. 6'7'9 In particular, most vasocon- 
stricting peptides interact with receptors linked to the 
phosphoinositide system) °-~2 Phosphoinositide hy- 
drolysis leads to the production of inositol trisphos- 
phate and diacylglycerol. Although inositol triphos- 
phate liberates Ca 2+ from intracellular stores, the 
major function of diacylglycerol is activation of 
PKC)  3 Phorbol esters, which directly activate 
PKC, 14 induce contraction in numerous vascular 
smooth muscles. 15-17 PKC translocation is temporally 
associated with agonist-induced vascular smooth 
muscle contraction) s In addition, similar late-phase 
phosphoproteins are phosphorylated and dephos- 
phorylated in agonist-induced contractions and in 
phorbol ester-induced contractions. 19 
The hypothesis of this investigation is that 
increases in [Ca2+]i and activation of MLCK are 
important for the initiation of Vascular smooth 
muscle contraction but that other kinases such as 
PKC are important for the sustained phase of vascular 
smooth muscle contraction. The purpose of this 
investigation was to produce xperimental conditions 
under which Ca 2 ÷-dependent signalling mechanisms 
were not operative. Under these conditions, agonists 
that increase intracellular Ca 2 + do not elicit smooth 
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Fig. 3. Dose responses of BCASM to PDBu in presence 
and absence of Ca 2 ÷. After baseline responses to KCI (110 
mmol/L) were determined, strips were placed in Ca 2+- 
containing or Ca2+-free (+4 mmol/L EGTA and 0.1 
mmol/L BAPTA) buffer for 60 minutes and then treated 
with PDBu at doses ranging from 10 nmol/L to 10 Ixmol/L 
(n = 5 for each dose of PDBu). Responses are displayed as 
percent of initial KCI contraction in Ca2+-containing 
buffer. There was no significant difference in magnitude of
contractile response in Ca2+-containing (triangles) or 
Ca2+-free (squares) conditions to doses of PDBu ranging 
from 10 nmol/L to 10 Ixmol/L. 
muscle contractions, whereas the phorbol ester, 
phorbol 12, 13-dibutyrate (PDBu), elicits slowly 
developing sustained contractions ofvascular smooth 
muscle. This model suggests that Ca2+-independent 
smooth muscle contractions that are operative 
through PKC activation. 
MATERIAL AND METHODS 
Chemicals and reagents. ML-9, KN-62, and 
phorbol esters were obtained from LC laboratories 
(Woburn, Mass.), endothelin-1 and staurosporine 
from Calbiochem (LaJolla, Calif.), the thromoxane 
analogue U46619 from Cayman Chemical (Ann 
Arbor, Mich.), Fura-2 from Molecular Probes (Eu- 
gene, Ore.), and aequorin from Friday Harbor 
Photoproteins (Friday Harbor, Wash.). 
Smooth muscle contractions. Bovine calf ca- 
rotid arteries were obtained at a local abattoir and 
dissected free of adventitial tissue. The arteries were 
opened longitudinally, and the endothelium was 
denuded with gentle rubbing of the intimal surface. 
Transverse strips, 1 to 2 mm in diameter, were cut, 
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Fig. 4. Contractile responses of BCASM to agonists in 
absence of Ca 2+. Contractile response of BCASM to doses 
of stable thromboxane agonist U46619 (TXB, 100 
~mol/L) and endothelin-1 (ET, 1 ~mol/L), which cause 
maximal contractions, were significantly attenuated in
absence (minus ign) of Ca 2+ (p < 0.05, n = 4)compared 
with Ca2+-containing conditions (plus sign). There was no 
significant difference in magnitude ofcontraction toPDBu 
(1 ~tmol/L) in presence or absence of Ca 2+. 
and a loop of surgical suture was tied to each end of 
the strip. The strips were mounted in an automated 
tissue bath system (Buxco Electronics, Troy, N.Y.). 
The strips were equilibrated in Krebs bicarbonate 
solution (NaC1 120 mmol/L, KC1 4.7 mmol/L, 
MgSO 4 1.0 mmol/L, NaH2PO 4 1.0 retool/L, glu- 
cose 10 mmol/L, CaCI 2 1.5 mmol/L, and Na2HCO 3 
25 mmol/L) at 37 ° C and gassed with 95% 0 2 and 
5% CO 2 for I hour. Initial responses to high extracel- 
lular KC1 (110 mmol/L with equimolar replacement 
of NaCl) were determined, and the data are reported 
as a percentage of this initial response. Subse- 
quently, the muscles were equilibrated in Ca 2÷- 
free conditions containing 4 mmol/L ethylene 
glycol-bis(13-aminoethylether) N, N, N', N'-tetra- 
acetic acid (EGTA) and 0.1 mmol/L 1,2-bis(2- 
aminophenoxy) ethane-N,N,N',N'-tetraacetic a id 
(BAPTA/acetyl methyl ester) (an intracellular cap 
cium chelator), for i hour. 2° Depletion ofextracellu- 
lar Ca 2÷ was confirmed by repeating the high extra- 
cellular KCI contraction. High KCI depolarizes the 
muscle membrane, allowing extracellular Ca 2 + to en- 
ter the cell. 
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Fig. 5, Intracellular Ca 2+ concentrations i  Ca2+-free conditions with photoprobe aequorin. 
Aequorin-loaded bovine carotid artery strips were equilibrated in Krebs Ringers bicarbonate 
solution containing 1.5 mmol/L Ca 2+. After 30 minutes strips were placed in Ca2+-free, 4 
mmol/L EGTA containing buffer for 60 minutes. Phorbol ester (PDBu) was then added. 
Intracellular [Ca2+]i progressively decreased during equilibration i Ca2+-free conditions and 
did not change with addition of phorbol ester. Calibrated values of [Ca2+]i are indicated in 
legend on right. 
Intracellular Ca 2+ stores were considered epleted 
when 5-hydroxytryptamine (5-HT) failed to elicit a 
response. Agonists were added irectly to the muscle 
baths in the appropriate dilutions, and the contrac- 
tions are reported as a percentage of the initial KC1 
contraction. 
Intracellular Ca 2+ determinations. Intracel- 
lular [Ca 2 + ]i was determined by use of aequorin and 
Fura-2 as Ca2+-indicators. 21'22 Strips of bovine ca- 
rotid artery were loaded with aequorin by use of a 
method that uses permeablizing solutions. The strips 
were placed sequentially into four solutions for 30 
minutes each: solution 1 :10  mmol/L EGTA, 5 
mmol/L Na2ATP, 120 mmol/L KCI, 2 mmol/L 
MgC12 20 mmol/L TES; solution 2:0.1 mmol/L 
EGTA 5 mmol/L Na2ATP, 120 mmol/L KC1, 2 
mmol/L C12, 20 mmol/L N-tris (hydroxymethyl) 
methyl-2-aminoethane sulfonic acid, aequorin 0.2 
mg/ml; solution 3:0.1 mmol/L EGTA, 5 mmol/L 
Na2ATP , 120 mmol/L KCl, 2 mmol/L MgCl2, 20 
mmol/L TES; solution 4 :5  mmol/L ATP, 120 
mmol/L NaC1, 3.5 mmol/L KCl, 1.5 mmol/L 
dextrose, 15.5 mmol/L NaHCOa, 10 mmol/L 
MgC12, 1.4 mmol/L NaH2PO 4. Aequorin signals 
and isometric tensions were measured sim- 
ultaneously as test substances were added to the 
reservoir by perifusion. Light output was detected 
with a photomultiplier tube interfaced with a com- 
puter. 
For Fura-2 determinations, smooth muscle cells 
were isolated with enzymatic digestion. Smooth 
muscle strips were incubated in Hepes buffer con- 
taining 3 mg/ml collagenase, 0.7 mg/ml elastase, 1
mg/ml hyaluronidase, 2 mg/ml ATP, 0.1 mg/ml 
deoxyribonuclease, 1 mg/ml trypsin inhibitor, 15 
mg/ml bovine serum albumin, 0.1 mmol/L Ca 2 + for 
30 minutes at 37 ° C. The smooth muscle ceils were 
pelleted with centrifugation a d washed three times 
in buffer. Dispersed smooth muscle cells were loaded 
with the Ca 2+ indicator Fura-2 (1 Ixmol/L) for 45" 
at 37 ° C and placed in a cuvette in a dual wavelength 
spectrophotometer (PTI, South Brunswick, N.I.) 
and fluorescence measured by use of excitation 
wavelengths of340/380 nmol/L and emission wave- 
lengths of 510 nmol/L. The intracellular Ca 2+ 
concentrations were calculated by use of the equa- 
tion [Ca2+]i = k d x (R - Rmin/Rma x - R) where 
k d = 224 nmol/L, R = the observed fluorescence, 
l~,a~ = maximal Ca 2+ concentration (that occurs 
with lysis of the cells), and Rmi n = minimal Ca 2+ 
concentration (i  the presence of 4 mmol/L EGTA). 
Statistical analysis. Statistical analysis was per- 
formed with use of a one-way analysis of variance 
(ANOVA), and differences were considered signifi- 
cant when thep value was less than 0.05. 
RESULTS 
Contractile responses of  carotid artery smooth 
muscle in the presence and absence of Ca 2÷. 
Carotid smooth muscle strips incubated in a Ca 2+- 
free buffer containing 4 mmol/L EGTA and 0.1 
mmol/L BAPTA for 60 minutes did not contract on 
addition of high extracellular KC1. Repeated addi- 
tions of 10 ~mol/L serotonin (5-HT) resulted in 
progressive decrease in the contractile response, 
suggesting that intracellular stores of Ca 2+ were 
progressively depleted (Fig. 1). Stimulation with 
PDBu in Ca2+-conraining, or Ca2+-free conditions, 
resulted in a slowly developing sustained contraction 
(Fig. 2). The tension reached a plateau by 60 
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minutes. The magnitude of the PDBu-induced con- 
traction, over a range of 10 nmol/L to 10 ixmol/L, 
was similar in the presence and absence of Ca 2+ (Fig. 
3). The magnitude of contractile responses to the 
thromboxane agonist U-46610 (100 Ixmol/L) and 
endothelin-1 (  txmol/L) were significantly greater in 
the presence of Ca 2+ compared to Ca2+-free condi- 
tions (Fig. 4). 
Effect of  Ca z +-free conditions on free cytosolic 
Ca 2+ concentrations. The effect of Ca 2 +-free 
conditions and of the addition of PDBu on intracel- 
lular Ca 2 + concentrations ([Ca 2 + ]c) was determined 
by use of aequorin as a Ca 2+ indicator. When 
extracellular Ca 2+ is removed, the [Ca2+]c in bovine 
carotid artery smooth muscle (BCASM) decreases 
(Fig. 5). The subsequent addition of 0.8 ~mol/L 
PDBu resulted in no change in [Ca2+]c. 
The intracellular Ca 2+ concentrations under 
CaZ+-free conditions were less than 10 nmol/L as 
determined with the Ca 2+ indicator, Fura-2. These 
Ca 2 + concentrations did not change with the addi- 
tion of 5-HT (1.0 or 10 ixmol/L), suggesting that 
intracellular Ca 2+ stores were significantly depleted. 
The effect of  protein ldnase inhibitors on 
Ca 2+-free phorbol ester induced contractions. To 
determine which kinases are operative in sustained 
vascular smooth muscle contraction under Ca2+-free 
conditions, the specific protein kinase inhibitors, 
ML-9 (an inhibitor of MLCK) and staurosporine (an 
inhibitor of PKC) were used. 23"24 Preincubation with 
ML-9 (50 ~mol/L) significantly inhibited KCI (110 
mmol/L) and 5-HT (10 ~xmol/L) contractions in 
Ca 2 +-containing buffer, yet there was minimal effect 
on a Ca2÷-free PDBu (300 nmol/L) contractions 
(Fig. 6). Preincubation with staurosporine (100 
nmol/L) did not significantly inhibit KCI (110 
retool/L) or 5-HT (10 txmol/L) contractions in 
Ca2+-containing buffer (Fig. 7). However, stauro- 
sporine (50 nmol/L) significantly inhibited Ca 2 + -free 
PDBu (300 nmol/L) contractions. 
DISCUSSION 
Vascular smooth muscle is unique in that sus- 
tained contractions can be maintained with minimal 
energy use. 6 This tonic contractile state may account 
for pathologic vasospastic states. Mthough Ca 2+- 
dependent activation of MLCK has been implicated 
in the rapid initiation of vascular smooth muscle 
contraction, 1 less is known about the cellular sig- 
nalling events that modulate the sustained phase of 
contraction that occurs in vasospasm. PKC activa- 
tion has been implicated in activating a kinase 
cascade that leads to a tonic contractile state. 6s 
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Fig. 6. The effect ofML-9, MLCK inhibitor, on Ca 2+- 
free PDBu contractions. BCASM strips were equilibrated 
in normal bicarbonate buffer. After baseline responses to 
KC1 (110 retool/L) were determined, some strips were 
placed in Ca 2 +-free (+ 4 mmol/L EGTA and 0.1 mmol/L 
BAPTA) buffer for 60 minutes. Strips were preincubated 
with ML-9 (10 to 100 ixmol/L) for 30 minutes and then 
KCL (110 mmol/L in Ca 2 + -containing buffer, closed stars), 
5-HT (10 ixmol/L in Ca2+-containing buffer, closed 
squares), or PDBu (300 nmol/L in Ca2+-free buffer, closed 
diamonds) were added. ML-9 (50 ~mol/L) significantly 
(asterisk) inhibited KCI (110 mmol/L) and 5-HT (10 
txmol/L) contractions in presence of Ca 2+ yet did not 
significantly inhibit PDBu (300 nmol/L) contractions in 
Ca2+-free conditions (p < 0.05 one-way ANOVA, n = 4 
for each dose of ML-9). 
Phorbol esters pharmacologically activate PKC and 
have been shown to induce vascular smooth muscle 
contraction.l~,16 
In this study, a model of Ca2+-independent 
vascular smooth muscle contraction was developed. 
The phorbol ester, PDBu, induced contraction in 
bovine carotid artery smooth muscle (BCASM) in 
the absence of extracellular Ca 2+ and under condi- 
tions where the intracellular Ca 2 + concentration was 
at a low and fixed level (Figs. 1 to 3). Under these 
Ca2+-free conditions, high extracellular KCI did not 
induce a contraction. The contraction elicited by 
repeated additions of the agonist serotonin progres- 
sively diminished to less than 5% of that which 
occurred when Ca 2+ was present (Fig. 1). Normal 
resting intracellular Ca 2 + concentrations in vascular 
smooth muscle are 150 to 200 nmol/L. 23 Under the 
Ca2+-free conditions used in this study, the intracel- 
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Fig. 7. Effect of staurosporine, PKC inhibitor on Ca 2÷- 
free PDBu contractions. BCASM strips were equilibrated 
in normal bicarbonate buffer. After baseline responses to 
KCI (110 mmol/L) were determined, some strips were 
placed in Ca2+-free (+ 4 mmol/L EGTA and 0.1 mmol/L 
BAPTA) buffer for 60 minutes. Strips were preincubated 
with staurosporine (10 to 1000 nmol/L) for 30 minutes 
and then KCL (110 mmol/L in Ca2+-containing buffer, 
closed squares), 5-HT (10 ~mol/L in Ca2+-containing 
buffer, closed triangles), or PDBu (300 nmol/L in Ca 2+-free 
buffer, closed diamonds) were added. Staurosporine (100 
nmol/L) significantly (asterisk) inhibited PDBu contrac- 
tions in Ca 2+-free conditions to greater extent than KC1 or 
5-HT contractions in presence of Ca 2+ (p < 0.05 one-way 
ANOVA, n = 4 for each dose of staurosporine). 
lular Ca 2 + concentration was less than 10 nmol/L and 
did not change with serotonin or PDBu stimulation 
(Fig. 4). 
Activation of  PKC and not MLCK leads to 
Ca2+-free PDBu-induced contractions in that Ca 2÷- 
free contractions were not inhibited by low concen- 
trations (50 ~mol/L) of the MLCK inhibitor ML-9, 
but Ca2+-dependent contractions induced by high 
extracellular KCI and 5-HT were inhibited by ML-9 
(Fig. 5). The EDs0 of ML-9 for MLCK in vitro is 4 
Ixmol/L and for PKC 54 p~mol/L. 2s Thus, at higher 
concentrations of ML-9 (100 ~mol/L), the inhibitor 
is probably producing complete inhibition of  KC1, 
5-HT, and PDBu contractions through inhibition of 
both MLCK and PKC. The PKC inhibitor, stauro- 
sporine (100 nmot/L), inhibits Ca2+-free PDBu 
contractions to a greater extent han Ca 2 +-dependent 
KC1 or 5-HT-induced contractions (Fig. 6). The 
ED5o of staurosporine for PKC in vitro is 7 nmol/L 
Ca 2+ 
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Fig. 8. Model of signalling mechanisms inVSM contrac- 
tion. Rapid rise in intracellular Ca 2+, that occurs when 
depolarization of smooth muscle membrane with high 
extracellular KC1 leads to rapid initiation of VSM contrac- 
tion (A) (solid line). Phorbol esters, PKC activators, induce 
slowly developing sustained contractions in presence or 
absence of Ca ~ + (B) (broken line). Composite of increase in 
intracellular Ca 2+ and PKC activation may account for 
initial and sustained aspects of agonist induced contractions 
(c).  
and for MLCK 13 nmol/L. 26 The relatively high 
doses of staurosporine required to inhibit muscle 
contractions in these experiments may be due to poor 
penetration of  the inhibitor into the muscle strips. 
The partial inhibition of KCI and 5-HT contractions 
may be due to overlap between PKC and MLCK 
inhibition. 
Phorbol ester induced contractions in Ca 2+-free 
conditions may be due to the activation of Ca 2÷- 
independent isoforms of PKC. Vascular smooth 
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muscle contains the CaZ+-dependent a-isoform and 
the calcium-independent -isoform. 27 Alternatively, 
phorbol esters may be overcoming the Ca 2+ require- 
ment of PKC for activation, zsFurther work is needed 
to determine which isoforms of PKC are operative in 
both physiologic and pharmacologic contractions of 
vascular smooth muscle. 
Ca2+-independent contractions were elicited in 
BCASM by the physiologically relevant hrombox- 
ane analogue (U46619) and endothelin (Fig. 4). The 
magnitude of these contractions were significantly 
less than the magnitude of contractions in the 
presence of Ca 2+. This is similar to what has been 
described for Ca 2 +-free ndothelin-induced contrac- 
tions in porcine coronary arteries and prostaglandin 
(PGFz~)-induced contractions single permeabilized 
ferret aorta cells. 24'29 Endothelin-induced, Ca2+-free 
contractions are inhibited by the PKC inhibitor 
H-7, 24 and the PGFz~-induced Ca2+-independent 
contractions were inhibited by staurosporine, 29 sug- 
gesting at least a partial role for PKC in agonist- 
induced Ca2+-independent smooth muscle con- 
traction. 
It has been suggested that PKC modulates 
sustained contraction through the activation of a 
kinase cascade that involves mitogen-activated pro- 
tein kinase, which leads to caldesmon phosphoryla- 
tion. 3° Caldesmon is a thin filament regulatory 
protein in smooth muscle that inhibits actinomyosin 
ATPase. This inhibition is reversed by the phosphor- 
ylation of caldesmon. 31 Thus it is possible that 
activation of "Ca2+-independent "' PKC pathways 
may lead to sustained vascular smooth muscle con- 
traction through the activation of a kinase cascade. 
Activation of PKC has been implicated in the 
pathologic vasospasm that accompanies cerebral 
vasospasmY ,33 In an animal model of subarachnoid 
hemorrhage-induced vasospasm, the PKC-mediated 
vascular smooth muscle contractions occurred in 
Ca2+-free media? ~ The possible role of Ca 2+- 
independent PKC activation in other acute vasospas- 
tic states has yet to be determined. 
These data support a model of vascular smooth 
muscle contraction where the initial rapid phase of 
contraction that occurs with depolarization of the 
membrane with KCI is caused by Ca2+-dependent, 
MLCK-mediated mechanisms (Fig. 8). However, 
the slowly developing tonic phase of vascular smooth 
muscle contraction can be pharmacologically induced 
with the PKC activators phorbol esters under cir- 
cumstances where the extracellular and intracellular 
Ca 2+ concentrations are low and fixed. Thus the 
sustained phase of vascular smooth muscle contrac- 
tion may be mediated by a kinase cascade that 
involves activation by PKC. This model of phorbol 
ester - induced  Ca 2 +-free vascular smooth contraction 
will be useful in further elucidating the subsequent 
intracellular signalling events that lead to tonic 
vascular smooth muscle contraction or vasospasm. 
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